Monte Rosa Therapeutics, Inc. (GLUE)

Balance Sheet (Trailing)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Quarter Ending	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31
Cash & Equivalents	143.64	351.41	368.76	358.79	169.6	42.86	-	-	-	9.25
Short-Term Investments	178.86	0	0	0	0	0	-	-	-	0
Cash & Cash Equivalents	322.5	351.41	368.76	358.79	169.6	42.86	0	0	0	9.25
Cash Growth	90.15%	719.84%	-	-	-	363.63%	-	-	-	-
Other Current Assets	-	-	1.76	-	2.11	0.73	-	-	-	0.51
Total Current Assets	320.37	348.67	370.52	358.29	171.71	43.59	-	-	-	9.76
Property, Plant & Equipment	20.31	12.33	11.8	8.92	7.73	4.62	-	-	-	1.34
Other Long-Term Assets	5.33	5.34	1.73	1.73	1.16	1.16	-	-	-	0
Total Long-Term Assets	25.64	17.66	13.53	10.65	8.9	5.79	-	-	-	1.34
Total Assets	346.01	366.33	384.05	368.94	180.6	49.38	-	-	-	11.09
Accounts Payable	4.51	6.56	3.53	7.46	7.33	7.07	-	-	-	3.2
Current Debt	1.52	0	0	0	0	0	-	-	-	0.75
Other Current Liabilities	6.46	10.08	9.21	3.33	1.77	22.21	-	-	-	0.35
Total Current Liabilities	12.49	16.64	12.74	10.79	9.09	29.28	-	-	-	4.29
Long-Term Debt	5.46	0	0	0	0	0	-	-	-	0
Other Long-Term Liabilities	2.18	2.18	2	1.47	0.96	1.07	-	-	-	-
Total Long-Term Liabilities	7.64	2.18	2	1.47	0.96	1.07	-	-	-	0
Total Liabilities	20.13	18.81	14.74	12.26	10.05	30.34	-	-	-	4.29
Total Debt	6.98	0	0	0	0	0	-	-	-	0.75
Common Stock	473.98	471.57	469.85	436.85	0.66	0.41	0	0	0	0.05
Retained Earnings	-145.97	-122.04	-98.6	-78.76	-60.35	-48.08	-	-	-	-12.2
Comprehensive Income	-2.13	-2.02	-1.95	-1.42	-0.92	-1.06	-	-	-	0
Shareholders' Equity	325.88	347.52	369.31	356.68	-60.62	-48.73	-	-	-	-12.15
Total Liabilities and Equity	346.01	366.33	384.05	368.94	-50.57	-18.39	0	0	0	-7.86
Net Cash / Debt	315.52	351.41	368.76	358.79	169.6	42.86	0	0	0	8.5
Net Cash / Debt Growth	86.03%	719.84%	-	-	-	404.57%	-	-	-	-
Net Cash Per Share	6.77	14.06	8.02	70.76	99.23	28.26	-	-	-	1.70
Working Capital	307.88	332.03	357.78	347.5	162.62	14.32	-	-	-	5.47
Book Value Per Share	6.99	13.90	8.03	70.34	-35.46	-32.12	-	-	-	-2.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).